Nadia Altomare
Directeur/Membre du Conseil chez Savran Technologies, Inc.
Fortune : 189 222 $ au 30/04/2024
Postes actifs de Nadia Altomare
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Savran Technologies, Inc.
 Savran Technologies, Inc. BiotechnologyHealth Technology Savran Technologies, Inc. provide and develops a technology to isolate ultra-rare cells from blood. The company was founded by Cagri Savran in 2018 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - | - |
| Patient Rights Advocate, Inc. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Nadia Altomare
Anciens postes connus de Nadia Altomare
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SERA PROGNOSTICS, INC. | Corporate Officer/Principal | 01/05/2017 | 09/06/2023 |
Abcodia Ltd.
 Abcodia Ltd. BiotechnologyHealth Technology Abcodia Ltd. engages in the validation and discovery of molecular biomarkers. The firm works alongside University College London and in partnership with diagnostic, pharmaceutical and technology companies to exploit a prospective serum bank for the purpose of ethical biomarker validation and discovery. The company was founded in 2010 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 25/05/2015 | 01/05/2017 |
| Directeur Général | 11/01/2016 | 01/05/2017 | |
| President | 25/05/2015 | 11/01/2016 | |
| THERMO FISHER SCIENTIFIC | Corporate Officer/Principal | 01/01/2012 | 01/01/2014 |
| REVVITY, INC. | Corporate Officer/Principal | 01/01/2011 | 01/01/2012 |
Formation de Nadia Altomare
| Northeastern University | Masters Business Admin |
| Stony Brook University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
| Royaume-Uni | 2 |
Opérationnelle
| Director/Board Member | 3 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SERA PROGNOSTICS, INC. | Health Services |
| THERMO FISHER SCIENTIFIC | Health Technology |
| REVVITY, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Abcodia Ltd.
Abcodia Ltd. BiotechnologyHealth Technology Abcodia Ltd. engages in the validation and discovery of molecular biomarkers. The firm works alongside University College London and in partnership with diagnostic, pharmaceutical and technology companies to exploit a prospective serum bank for the purpose of ethical biomarker validation and discovery. The company was founded in 2010 and is headquartered in London, the United Kingdom. | Health Technology |
Savran Technologies, Inc.
Savran Technologies, Inc. BiotechnologyHealth Technology Savran Technologies, Inc. provide and develops a technology to isolate ultra-rare cells from blood. The company was founded by Cagri Savran in 2018 and is headquartered in Cambridge, MA. | Health Technology |
| Patient Rights Advocate, Inc. |
- Bourse
- Insiders
- Nadia Altomare
- Expérience
